A Phase III Randomized Trial Comparing Efficacy, Safety, and Immunogenicity of ZRC-3285 vs. Eylea(®) in Patients with Wet Age-Related Macular Degeneration.

Bansal M, Singh P, Mehta RK, Laul RS, Rana P, Shah U, Vohra R, Desai S, Bhomaj S, Patwardhan S, Manoher JM, Sapar A, Parwal S, Amabde AK, Shroff R, Natesh S, Biswas RK, D LR, Sinha BP, C K M, Patel E, Kamble A, Bhende P, Patil S, Shah A, Narula R, Kumari B, Bathula L, Kirtane S, Darji B, Doshi M, Parmar D

Open source

DOI: 10.1007/s40123-025-01299-5
Published: 2026 Feb
Container: Ophthalmology and therapy
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40123-025-01299-5,
  title = {A Phase III Randomized Trial Comparing Efficacy, Safety, and Immunogenicity of ZRC-3285 vs. Eylea(®) in Patients with Wet Age-Related Macular Degeneration.},
  author = {Bansal M and Singh P and Mehta RK and Laul RS and Rana P and Shah U and Vohra R and Desai S and Bhomaj S and Patwardhan S and Manoher JM and Sapar A and Parwal S and Amabde AK and Shroff R and Natesh S and Biswas RK and D LR and Sinha BP and C K M and Patel E and Kamble A and Bhende P and Patil S and Shah A and Narula R and Kumari B and Bathula L and Kirtane S and Darji B and Doshi M and Parmar D},
  year = {2026},
  journal = {Ophthalmology and therapy},
  doi = {10.1007/s40123-025-01299-5},
  url = {https://doi.org/10.1007/s40123-025-01299-5}
}

RIS

TY  - JOUR
TI  - A Phase III Randomized Trial Comparing Efficacy, Safety, and Immunogenicity of ZRC-3285 vs. Eylea(®) in Patients with Wet Age-Related Macular Degeneration.
AU  - Bansal M
AU  - Singh P
AU  - Mehta RK
AU  - Laul RS
AU  - Rana P
AU  - Shah U
AU  - Vohra R
AU  - Desai S
AU  - Bhomaj S
AU  - Patwardhan S
AU  - Manoher JM
AU  - Sapar A
AU  - Parwal S
AU  - Amabde AK
AU  - Shroff R
AU  - Natesh S
AU  - Biswas RK
AU  - D LR
AU  - Sinha BP
AU  - C K M
AU  - Patel E
AU  - Kamble A
AU  - Bhende P
AU  - Patil S
AU  - Shah A
AU  - Narula R
AU  - Kumari B
AU  - Bathula L
AU  - Kirtane S
AU  - Darji B
AU  - Doshi M
AU  - Parmar D
PY  - 2026
JO  - Ophthalmology and therapy
DO  - 10.1007/s40123-025-01299-5
UR  - https://doi.org/10.1007/s40123-025-01299-5
ER  -

APA

M, B., P, S., RK, M., RS, L., P, R., U, S., R, V., S, D., S, B., S, P., JM, M., A, S., S, P., AK, A., R, S., S, N., RK, B., LR, D., BP, S., M, C. K., E, P., A, K., P, B., S, P., A, S., R, N., B, K., L, B., S, K., B, D., M, D., & D, P. (2026). A Phase III Randomized Trial Comparing Efficacy, Safety, and Immunogenicity of ZRC-3285 vs. Eylea(®) in Patients with Wet Age-Related Macular Degeneration.. Ophthalmology and therapy. https://doi.org/10.1007/s40123-025-01299-5

Source records

pubmed · retrieved 2026-09-25T21:16:34.338Z
europe-pmc · retrieved 2026-09-25T21:16:34.351Z
doaj · retrieved 2026-09-25T21:16:34.369Z